Company intelligence / Profile preview

Laboratorios Filaxis

Martinez, Buenos Aires, Argentina

Ownership: Private
Development stage: Other

Overview

Laboratorios Filaxis specialized in manufacturing, commercialization, and development of pharmaceutical products, particularly with leadership in oncology and HIV treatments in Argentina. It was acquired by Fresenius Kabi in 2006.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Laboratorios Filaxis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorios Filaxis.

Explore the full profile